Fujifilm Diosynth Biotechnologies has chosen Holly Springs in North Carolina as the site of its new large-cell culture production site in the US. The company first...
Fujifilm Diosynth Biotechnologies, a subsidiary of Japan’s Fujifilm Corp., has announced plans to spend more than $2 billion to build a new large-scale cell culture...
13.03.2019
- Japan’s Fujifilm is boosting its healthcare business with the proposed acquisition of Biogen (Denmark) Manufacturing for around $890 million in cash. The deal gives Fujifilm a...
26.04.2018
- Mylan has joined forces with Japan’s Fujifilm Kyowa Kirin Biologics to commercialize a biosimilar to Abbvie’s Humira (adalimumab) that has been developed by the Japanese company...
19.10.2016
- The $2 billion initial public offering launched last week in Hong Kong by Chinese state-backed China Resources Pharmaceutical, the country’s second-largest drugmaker, attracted...
15.05.2015
- India-based generics producer Dr Reddy's Laboratories is pleased with its performance in fiscal 2015 (March 31) achieved despite currency volatility in some emerging market...
01.04.2015
- Fujifilm announced that it will acquire Cellular Dynamics International (CDI) for $307 million via an all-cash tender offer to be followed by a second step merger. Under the terms...
